Skip to Main Content

Author Details

Andreas Scherer
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
1995
56
22
PMIDPaper TitleJournal TitlePublished Year
36229534Glomerular proteomic profiling of kidney biopsies with hypertensive nephropathy reveals a signature of disease progression.Hypertens Res2023
36229534Glomerular proteomic profiling of kidney biopsies with hypertensive nephropathy reveals a signature of disease progression.Hypertens Res2023
37884999The Quartet Data Portal: integration of community-wide resources for multiomics quality control.Genome Biol2023
37884999The Quartet Data Portal: integration of community-wide resources for multiomics quality control.Genome Biol2023
35118162Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium.Mol Ther Methods Clin Dev2022
36310597Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report.Front Mol Biosci2022
35931808A multiomics disease progression signature of low-risk ccRCC.Sci Rep2022
34980216Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.Genome Biol2022
35118162Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium.Mol Ther Methods Clin Dev2022
36310597Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report.Front Mol Biosci2022
35931808A multiomics disease progression signature of low-risk ccRCC.Sci Rep2022
34980216Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.Genome Biol2022
33091118Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.Clin Infect Dis2021
32055842Exploration of databases and methods supporting drug repurposing: a comprehensive survey.Brief Bioinform2021
33846644Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.Nat Biotechnol2021
33863366A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Genome Biol2021
33863344Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Genome Biol2021
33091118Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.Clin Infect Dis2021
34789871Reporting guidelines for human microbiome research: the STORMS checklist.Nat Med2021
34504347Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.Nat Biotechnol2021
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
34949218Author Correction: The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
34930263AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.Cancer Cell Int2021
34872606The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
33846644Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.Nat Biotechnol2021
33863366A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Genome Biol2021
33863344Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Genome Biol2021
34949218Author Correction: The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
34872606The SEQC2 epigenomics quality control (EpiQC) study.Genome Biol2021
34930263AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.Cancer Cell Int2021
34789871Reporting guidelines for human microbiome research: the STORMS checklist.Nat Med2021
34504347Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.Nat Biotechnol2021
34504346Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Nat Biotechnol2021
32055842Exploration of databases and methods supporting drug repurposing: a comprehensive survey.Brief Bioinform2021
31134766AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.Physiol Rep2019
31134766AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.Physiol Rep2019
30838877Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.Am J Physiol Renal Physiol2019
30838877Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.Am J Physiol Renal Physiol2019
29534467Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.Int J Mol Sci2018
30039368Detection of CNVs in NGS Data Using VS-CNV.Methods Mol Biol2018
29534467Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.Int J Mol Sci2018
30039368Detection of CNVs in NGS Data Using VS-CNV.Methods Mol Biol2018
28596300Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.Physiol Rep2017
28596300Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.Physiol Rep2017
28450744Bridging the translational innovation gap through good biomarker practice.Nat Rev Drug Discov2017
28490671Matched preclinical designs for improved translatability.Sci Transl Med2017
29084770Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.Dis Model Mech2017
28290208Reproducibility in biomarker research and clinical development: a global challenge.Biomark Med2017
28450744Bridging the translational innovation gap through good biomarker practice.Nat Rev Drug Discov2017
28290208Reproducibility in biomarker research and clinical development: a global challenge.Biomark Med2017
  • 1 - 50 of 112

Recommended Authors

Hailiang Mei
Leiden University Medical Center
Career Start Year 2014
Number of shared co-authors 4
Felix Eichinger
University of Michigan ann arbor
Career Start Year 2006
Number of shared co-authors 2
Suzanne S Fei
Oregon National Primate Research Center
Career Start Year 2005
Number of shared co-authors 3
Arnaud Droit
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Career Start Year 2005
Number of shared co-authors 0
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 1
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
Brigham H Mecham
Center for Cancer Innovation, University of Washington
Career Start Year 2003
Number of shared co-authors 0
Purvesh Khatri
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 7
Winston Patrick Kuo
Harvard School of Dental Medicine
Career Start Year 2001
Number of shared co-authors 11
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 5
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 2
David K Crossman
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
Victor Segura
Center for Applied Medical Research (CIMA)
Career Start Year 2000
Number of shared co-authors 2
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 18
Wenjun Ju
University of Michigan ann arbor
Career Start Year 1998
Number of shared co-authors 2
Rajasree Menon
University of Michigan Medical School ann arbor
Career Start Year 1996
Number of shared co-authors 2
Clemens D Cohen
Medical Clinic and Policlinic IV, University of Munich
Career Start Year 1996
Number of shared co-authors 2
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
Gary Hardiman
Institute for Global Food Security, Queen's University Belfast
Career Start Year 1994
Number of shared co-authors 1
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 3
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 1993
Number of shared co-authors 2
Matthias Kretzler
University of Michigan ann arbor
Career Start Year 1992
Number of shared co-authors 2
Erwin P Bottinger
Hasso Plattner Institute for Digital Health at Mount Sinai
Career Start Year 1992
Number of shared co-authors 5
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
John Quackenbush
Harvard T. H. Chan School of Public Health
Career Start Year 1989
Number of shared co-authors 19
Johan Lindberg
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 2
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 18

Collaborators

Weida Tong
National Center for Toxicological Research
Co-authored papers 13
Ming Shi
Co-authored papers 10
Huixiao Hong
Co-authored papers 10
Charles Wang
Co-authored papers 7
Dalila B Megherbi
Co-authored papers 7
Rebecca Kusko
Immuneering Corporation
Co-authored papers 7
Baitang Ning
Co-authored papers 7
Joshua Xu
Co-authored papers 7
Frank Staedtler
Co-authored papers 7
Wendell D Jones
Department of Bioinformatics and Clinical Systems
Co-authored papers 6
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers 6
Jonathan Foox
Co-authored papers 6
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers 6
Pierre R Bushel
Co-authored papers 6
Tieliu Shi
Co-authored papers 6
Jessica Nordlund
Uppsala University
Co-authored papers 5
Zhichao Liu
Co-authored papers 5
Cesare Furlanello
Bruno Kessler Foundation
Co-authored papers 5
James C Willey
Co-authored papers 5
Hong Fang
National Center for Toxicological Research (NCTR)
Co-authored papers 5
Wenjun Bao
SAS Institute Inc Cary
Co-authored papers 5
Xiaohui Fan
College of Life Sciences, Zhejiang University
Co-authored papers 4
Quan-Zhen Li
Co-authored papers 4
Wenzhong Xiao
Stanford University
Co-authored papers 4
Ulrika Liljedahl
Co-authored papers 4
Chunlin Xiao
Chongqing Aier Eye Hospital
Co-authored papers 4
Zhiguang Li
Co-authored papers 4
Jean Thierry-Mieg
Co-authored papers 3
Kelci Miclaus
Co-authored papers 3
Roderick V Jensen
Virginia Tech
Co-authored papers 3
Release 1.2